Medical Research Commercialisation Fund III Overview

  • Fund Strategy
  • Venture

  • Fund Status
  • Closed

  • Size

  • Vintage
  • 2015

Vintage

  • Dry Powder

Medical Research Commercialisation Fund III General Information

Description

Medical Research Commercialisation Fund III is a venture capital fund co-managed by Brandon Biocatalyst and Brandon Capital. The fund is located in Melbourne, Australia.

Contact Information

Fund Category
Venture Capital
Close Date
Fund Family
Medical Research Commercialisation Fund
Medical Research Commercialisation Fund
Native Currency
AUD
Fund Manager's Location
  • Level 9
  • 31 Queen Street
  • Melbourne, Victoria 3000
  • Australia
+61 (03)
Fund Domiciles
Australia

Medical Research Commercialisation Fund III Investments (17)

Medical Research Commercialisation Fund III has made a total of 17 investments. Its most recent deal was a with Ena Respiratory for . The deal was made on 15-Jun-2021.

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Ena Respiratory 15-Jun-2021 Drug Discovery Clinical Trials - General
Longas 23-Jan-2021 Biotechnology Generating Revenue
Azura Ophthalmics 22-Oct-2020 Drug Discovery Clinical Trials - Phase 3
EBR Systems 04-Oct-2019 Therapeutic Devices Generating Revenue
Denteric 26-Sep-2019 Drug Discovery Generating Revenue
Paragen Bio 14-Aug-2018 Biotechnology Generating Revenue
Okogen 27-Feb-2018 Drug Discovery Pre-Clinical Trials
QUE Oncology 05-Jun-2017 Drug Discovery Pre-Clinical Trials
OncoRes Medical 02-Jun-2017 Early Stage VC (Series A) Diagnostic Equipment Pre-Clinical Trials
MetaBloQ 08-Mar-2017 Early Stage VC Biotechnology Startup
You’re viewing 10 of 17 investments. Get the full list »

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Medical Research Commercialisation Fund III Investment Strategy

Investments by Industry

Investments by Deal Type

PitchBook helps you see a fund’s investments based on target industry, year and deal type—so you can quickly understand its strategy at a glance.

Request a free trial

Medical Research Commercialisation Fund III Limited Partners (5)

AustralianSuper is one of Medical Research Commercialisation Fund III’s 5 limited partners. Its latest Original was on 20-Apr-2015.

Limited Partner Name Type Status Commitment Date Commitment Type
AustralianSuper Current 20-Apr-2015 Original
HESTA Industry Super Fund Current 20-Apr-2015 Original
Hostplus Superannuation Fund Current 20-Apr-2015 Original
Hostplus Superannuation Fund Current 20-Apr-2015 Secondary
Statewide Super Corporate Pension Former 20-Apr-2015 Original
To view Medical Research Commercialisation Fund III’s complete limited partners history, request access »

Medical Research Commercialisation Fund III Returns Data

The below charts are illustrative of the type of graphical data available to our clients and do not represent live data.

IRR (%)

 

DPI (x)

 

RVPI (x)

 

TVPI (x)

 

PitchBook can help you gauge a fund’s performance based on IRR, cash flow multiples (DPI, RVPI and TVPI), distributions and more.

Request a free trial

Medical Research Commercialisation Fund III Returns History

Period Contribution (by all LPs) Dry Powder Distribution (to all LPs) NAV Total Fund Distr+NAV IRR DPI RVPI TVPI Dry Powder %

This information is available in the PitchBook Platform. To explore Medical Research Commercialisation Fund III‘s full profile, request access.

Request a free trial

Medical Research Commercialisation Fund III FAQs

  • What is Medical Research Commercialisation Fund III?

    Medical Research Commercialisation Fund III is a venture capital fund co-managed by Brandon Biocatalyst and Brandon Capital.

  • Who manages Medical Research Commercialisation Fund III?

    Medical Research Commercialisation Fund III is managed by Brandon Capital and Brandon Biocatalyst.

  • Where is Medical Research Commercialisation Fund III domiciled?

    Medical Research Commercialisation Fund III is domiciled in Australia.

  • What is Medical Research Commercialisation Fund III's size?

    Medical Research Commercialisation Fund III has a size of .

  • What type of fund is Medical Research Commercialisation Fund III?

    The fund type of Medical Research Commercialisation Fund III is Venture.

  • What is the status of Medical Research Commercialisation Fund III?

    Medical Research Commercialisation Fund III is closed.

  • What has Medical Research Commercialisation Fund III invested in?

    Medical Research Commercialisation Fund III has made numerous investments in companies like Ena Respiratory, Longas, and Azura Ophthalmics within the Drug Discovery and Biotechnology industries.

  • What has Medical Research Commercialisation Fund III invested in recently?

    Medical Research Commercialisation Fund III's latest investment was on 15-Jun-2021 in Ena Respiratory, a company within the Drug Discovery industry.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process